Opus Genetics price target raised to $16 by Chardan Capital
Chardan Capital raised its price target for Opus Genetics to $16.00 per share from $13.00, per TradingView News ratings actions compiled by Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.